Circulating tumor <scp>HPV DNA</scp> in the management of <scp>HPV</scp> + oropharyngeal cancer and its correlation with <scp>MRI</scp>

ctHPVDNA was superior to p16 in identification of HPV-OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow-up protocol of OPSCC patients.